Trial Summary
What is the purpose of this trial?
The purpose of this investigation is to evaluate maternal and fetal outcomes following fetoscopic repair of fetal spina bifida at the Johns Hopkins Hospital. The hypothesis of this study is that fetoscopic spina bifida repair is feasible and has the same effectiveness as open repair of fetal spina bifida, but with the benefit of significantly lower maternal and fetal complication rates. The fetal benefit of the procedure will be the prenatal repair of spina bifida. The maternal benefit of fetoscopic spina bifida repair will be the avoidance of a large uterine incision. This type of incision increases the risk of uterine rupture and requires that all future deliveries are by cesarean section. The use of the minimally invasive fetoscopic surgical technique may also lower the risk of preterm premature rupture of membranes and preterm birth compared to open fetal surgery. Finally, successful fetoscopic spina bifida repair also makes vaginal delivery possible.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Fetoscopic Repair for Spina Bifida?
How does the fetoscopic repair treatment for spina bifida differ from other treatments?
Fetoscopic repair for spina bifida is a minimally invasive treatment that aims to improve neurological outcomes for the baby while reducing trauma to the mother compared to traditional open fetal surgery. It involves using small instruments and a camera inserted through tiny incisions, which minimizes the risk of complications like uterine rupture in future pregnancies.14567
Research Team
Jena B Miller, MD
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for pregnant women aged 18 or older with a single baby diagnosed with isolated fetal spina bifida, where the defect is between T1-S1 vertebrae. The pregnancy should be between 19 to almost 26 weeks along, and the fetus must have a normal karyotype. Women under 18, carrying multiples, having additional fetal anomalies, facing technical issues for surgery, placenta previa or certain maternal health risks are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Fetoscopic Repair
Participants undergo fetoscopic repair of fetal spina bifida
Follow-up
Participants are monitored for safety and effectiveness after fetoscopic repair
Early Childhood Follow-up
Monitoring of early childhood outcomes including motor function and neurodevelopmental assessments
Treatment Details
Interventions
- Fetoscopic Repair
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor